Yichang Hec Changjiang Pharmaceutical Co Ltd

Yichang Hec Changjiang Pharmaceutical Co Ltd

Health CarePharmaceuticals & Biotechnology
  • Price (HKD)17.24
  • Today's Change0.24 / 1.41%
  • Shares traded785.40k
  • 1 Year change8.43%
  • Beta--
Data delayed at least 15 minutes, as of May 25 2017 08:59 BST.
More ▼

Events & Activity

  • 1558:HKG trading volume exceeds daily average by +217.00%
  • 1558:HKG price moved over +1.73% to 17.68
  • 1558:HKG price rises above 15-day moving average to 17.50 at 15:01 BST
  • 1558:HKG price falls below 15-day moving average to 17.38 at 14:49 BST

Key statistics

On Thursday, Yichang Hec Changjiang Pharmaceutical Co Ltd (1558:HKG) closed at 17.24, -6.41% below its 52-week high of 18.42, set on Sep 08, 2016.
52-week range
13.82Dec 16 201618.42Sep 08 2016
Markit short selling activity
Previous close17.00
Average volume365.50k
Shares outstanding452.02m
Free float124.55m
P/E (TTM)18.10
Market cap7.81bn HKD
EPS (TTM)0.9549 HKD
Annual div (ADY)0.3391 HKD
Annual div yield (ADY)1.99%
Div ex-dateJun 08 2016
Div pay-dateJul 15 2016
Next div ex-dateJun 08 2017
Next div pay-dateJul 14 2017
Data delayed at least 15 minutes, as of May 25 2017 08:59 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.